Form 8-K · Current report

Lam Research 8-K, filed Aug 27, 2026

Filed
CIK
0000707549
Accession no.
0000707549-26-000043
AI-generated summary

Summary

Sohail U. Ahmed and Michael R. Cannon notified Lam Research's board on August 24, 2026 that they will retire from the board effective November 2, 2026, at which point the board will shrink from 12 to 10 directors.

Key points

  • Ahmed served about seven years on the board, including two years each on the audit, compensation and human resources, and innovation and technology committees.
  • Cannon served about 16 years on the board, including 12 years on the audit committee and 15 years on the nominating and governance committee, seven of them as its chair.
  • The board's size will be reduced from 12 to 10 directors upon the retirements.

Written by an AI model from the filing text. It can be incomplete or wrong; the filing on SEC.gov is the record.

Items reported

  • 5.02Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain Officers

From the filing

Item 5.02. Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain Officers 3 SIGNATURES 4 Table of Contents Item 5.02. Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain Officers On August 24, 2026, Sohail U. Ahmed and Michael R. Cannon each notified the Board of Directors (the “Board”) of Lam Research Corporation (the “Company”) of their respective decisions to retire from the Board, effective November 2, 2026. The size of the Board will be reduced from 12 to 10 directors effective upon the retirement of Messrs. …

An excerpt of the text as filed with the SEC, cut for length.

Readster writes AI-generated summaries of public filings for research purposes only. Summaries can be incomplete or wrong — check the original filing on SEC.gov before relying on it. Nothing here is investment, legal or medical advice.

Follow Lam Research in Readster

Add Lam Research to your watchlist and its SEC filings reach your brief alongside the news about it, every line cited to its source. Readster also follows topics, people, newsletters and podcasts.

No credit card. When the trial ends, you move to Readster Free unless you subscribe.